1. Home
  2. ELVN vs PL Comparison

ELVN vs PL Comparison

Compare ELVN & PL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • PL
  • Stock Information
  • Founded
  • ELVN 2016
  • PL 2010
  • Country
  • ELVN United States
  • PL United States
  • Employees
  • ELVN N/A
  • PL N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • PL Aerospace
  • Sector
  • ELVN Health Care
  • PL Industrials
  • Exchange
  • ELVN Nasdaq
  • PL Nasdaq
  • Market Cap
  • ELVN 927.8M
  • PL 947.7M
  • IPO Year
  • ELVN 2020
  • PL N/A
  • Fundamental
  • Price
  • ELVN $18.42
  • PL $3.56
  • Analyst Decision
  • ELVN Strong Buy
  • PL Buy
  • Analyst Count
  • ELVN 4
  • PL 11
  • Target Price
  • ELVN $39.25
  • PL $5.53
  • AVG Volume (30 Days)
  • ELVN 260.6K
  • PL 3.0M
  • Earning Date
  • ELVN 05-13-2025
  • PL 06-04-2025
  • Dividend Yield
  • ELVN N/A
  • PL N/A
  • EPS Growth
  • ELVN N/A
  • PL N/A
  • EPS
  • ELVN N/A
  • PL N/A
  • Revenue
  • ELVN N/A
  • PL $244,352,000.00
  • Revenue This Year
  • ELVN N/A
  • PL $14.08
  • Revenue Next Year
  • ELVN N/A
  • PL $21.49
  • P/E Ratio
  • ELVN N/A
  • PL N/A
  • Revenue Growth
  • ELVN N/A
  • PL 10.72
  • 52 Week Low
  • ELVN $13.30
  • PL $1.67
  • 52 Week High
  • ELVN $30.03
  • PL $6.71
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 47.86
  • PL 52.59
  • Support Level
  • ELVN $17.76
  • PL $3.38
  • Resistance Level
  • ELVN $20.79
  • PL $3.59
  • Average True Range (ATR)
  • ELVN 1.37
  • PL 0.16
  • MACD
  • ELVN 0.12
  • PL 0.07
  • Stochastic Oscillator
  • ELVN 45.39
  • PL 84.56

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About PL Planet Labs PBC

Planet Labs PBC is an Earth-imaging company. The company provides daily satellite data that helps businesses, governments, researchers, and journalists understand the physical world and take action.

Share on Social Networks: